Cargando…
Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients
T cells play a fundamental role in the early control and clearance of many viral infections of the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically reduced CD4(+) and CD8(+) T cells correlates with Coronavirus disease 2019 (COVID-19)-associated disease severity an...
Autores principales: | Lafon, Eliott, Diem, Gabriel, Witting, Christina, Zaderer, Viktoria, Bellmann-Weiler, Rosa Maria, Reindl, Markus, Bauer, Angelika, Griesmacher, Andrea, Fux, Vilmos, Hoermann, Gregor, Miller, Carl, Zabernigg, August, Wöll, Ewald, Wilflingseder, Doris, Lass-Flörl, Cornelia, Posch, Wilfried |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237940/ https://www.ncbi.nlm.nih.gov/pubmed/34194438 http://dx.doi.org/10.3389/fimmu.2021.684014 |
Ejemplares similares
-
Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern
por: Lafon, Eliott, et al.
Publicado: (2022) -
Salivary IgAs and Their Role in Mucosal Neutralization of SARS-CoV-2 Variants of Concern
por: Diem, Gabriel, et al.
Publicado: (2022) -
Dexamethasone Creates a Suppressive Microenvironment and Promotes Aspergillus fumigatus Invasion in a Human 3D Epithelial/Immune Respiratory Model
por: Luvanda, Maureen K., et al.
Publicado: (2021) -
ColdZyme® protects airway epithelia from infection with BA.4/5
por: Viktoria, Zaderer, et al.
Publicado: (2022) -
Correction: ColdZyme® protects airway epithelia from infection with BA.4/5
por: Zaderer, Viktoria, et al.
Publicado: (2023)